COSMOS Pharmaceutical Corporation
CSMYF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.16B
Close$
$-3.48
108.7% downside
Current Fair Value
108.7% downsideOvervalued by 108.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.16 Billion |
|---|---|
| Enterprise Value | $20.81 Billion |
| Annual dividend | $0.52 |
| Dividend yield | 1.29% |
| Earnings per Share | $405.05 |
| Beta | 0.15 |
| Outstanding Shares | 79,257,000 |
Return
| Return on Equity | 11.32% |
|---|---|
| Return on Assets | 5.39% |
| Return on Invested Capital | 12.40% |
Valuation & Multiples
| P/E Ratio | 15.67 |
|---|---|
| PEG | 1600.11 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.02 |
| Enterprise Value to EBIT | 0.47 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 3.8 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 13, 2026
EPS Estimate
$0.64
Consensus analyst estimateRevenue Estimate
$1.82 B
Consensus analyst estimateNext Earnings Call
Expected Date
January 8, 2027
EPS Estimate
$0.53
Consensus analyst estimateRevenue Estimate
$1.80 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About COSMOS Pharmaceutical Corporation
5,984 employees
CEO: Hideaki Yokoyama
COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, hea...